Pyrazoles as inhibitors of tumor necrosis factor
US7541368B2 · kind B2 · utility
1Cited by
0References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 1, 2005 |
| Grant date | Jun 2, 2009 |
| Priority date | — |
| Expiry date | Jun 15, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of Formula (I)and ester prodrugs, pharmaceutically acceptable salts or solvates of such compounds; or ester prodrugs of such salts or solvates; pharmaceutical compositions comprising such compounds, their preparation, and their pharmaceutical use in the treatment of disease states capable of being modulated by the inhibition of p38 kinase and/or tumor necrosis factor (TNF).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.